News

Digital pathology industry veteran, Joel Duckworth will lead Ibex’s growth in the Americas as Chief Revenue Officer

Ibex’s Galen™ Breast is rolled out as a first read application, helping pathologists improve accuracy, reduce turnaround time and streamline reporting

Globally renowned oncology center Institut Curie is leading a study on Ibex’s  Galen™ Breast, the first AI-based solution used by pathologistsb in routine clinical practice for breast cancer detection.

Ibex strengthens its focus on the US market with seasoned health executives to accelerate delivery of its AI-powered cancer diagnosis vision to healthcare networks, payors and policy makers

The ISO 13485 certification validates Ibex Medical Analytics’ position as a leading and quality-focused solution provider for healthcare organizations

Ibex was selected among the first ever winners of the AI in Health and Care Award, sharing £50 million to enable a study of Ibex’s AI technology across multiple NHS trusts

CorePlus completes deployment of Ibex Medical Analytics’ Galen™ Prostate solution to support pathologists in accurate diagnosis, enhanced lab efficiency and quality control

The Lancet Reports Outstanding Performance of Ibex Medical Analytics’ AI-based Algorithm in a Study at UPMC

New Milestone for Cancer Diagnostics in France as Ibex Medical Analytics Deploys its AI-Based Technology for Pathology at Medipath

UK’s First Rollout of AI-based Cancer Detection for NHS Patients as Pathology Provider LDPath Teams Up with Ibex Medical Analytics

Ibex’s Galen™ Prostate solution demonstrates outstanding results in a blinded study and supports pathologists in providing accurate diagnosis, enhanced lab efficiency and quality control

The Ibex Second Read™ System for breast is now deployed at Maccabi's pathology institute, making it the first lab in the world to implement AI-powered cancer diagnostics for breast biopsies in its routine clinical practice

Stuart Shand Joins Ibex Medical Analytics' management team as Chief Commercial Officer. Shand’s extensive experience in the digital pathology market will help grow the company’s business

Inspirata and IBEX Medical Analytics announce new technical partnership at the European Congress of Pathology (ECP) enabling joint customers to utilise artificial intelligence-based image analysis to reduce cancer case turnaround time and mitigate diagnostic errors.

Ibex Medical Analytics is among DigitalHealth.London's 20 new digital health care innovators. The prestigious accelerator has recently announced the innovators to be supported by the 2019-20 program at a launch event in central London.

Ibex Medical Analytics, a pioneer in Artificial Intelligence-based cancer diagnostics, and Medipath, the largest network of private pathology labs in France, announce today a partnership, designed to introduce artificial intelligence to the workflow in Medipath’s pathology labs and co-develop the next generation of Ibex’s product suite.

Ibex Medical Analytics, the pioneer in artificial intelligence (AI)-based cancer diagnostics, announces today that Dr. Ajit Singh, managing director of Artiman Ventures, a Silicon Valley based VC firm, is joining its advisory board.

Hillel's tech corner column on the Jerusalem post covering Ibex's work in the area of AI-based cancer diagnostics

Ibex Medical Analytics, a pioneering developer of AI-driven computational pathology cancer diagnosis system, completed an $11 million Series A funding round led by aMoon Fund.

The latest developments in the work done by health Providers around the development of AI-Enabled Pathology Tools

Ibex Medical Analytics and UPMC join forces for advancing AI-based prostate cancer diagnostics.

Ibex Medical Analytics deploys the first ever AI-based digital pathology cancer diagnosis system in live clinical setting, with immediate impact on patient care.

Maccabi Healthcare Services, which runs a pathology institute responsible for 160,000 histology accessions every year, recently started leveraging Ibex Medical Analytics’ Second Read system.